NEW YORK (GenomeWeb) – Trovagene and Boreal Genomics said today that they have agreed to merge their respective technologies in order to co-develop assay kits for the detection and analysis of circulating tumor DNA in urine and blood, which they plan to launch in 2017.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.